Celcuity's gedatolisib, a dual PI3K/mTOR inhibitor, shows promise in Phase 3 breast cancer trials. Click here to read an ...

At this time, I would like to welcome everyone to the Karyopharm Therapeutics fourth quarter and full year 2024 financial results conference call. There will be a question-and-answer session to follow ...

Panelists discuss how the Bayesian network meta-analysis showed which Janus kinase (JAK) inhibitors were most effective in ...

The Martin’s Mill Mustangs entered the 2025 postseason ranked number one in the 2A ranks, and they looked the part on Monday ...

Ubisoft has released its latest earnings report revealing the company's revenue has dropped by 31.4% year-on-year, and more ...

THE Welsh Open is closing in on a thrilling finale in Llandudno – with two crunch semi-finals TODAY! Former world champion ...

Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...

Logan Sargeant's Formula 1 departure once again led to an absence of Americans on the European dominated racing circuit. Ex-Haas boss Guenther Steiner told UPI he expects another American driver in ...